Monograph Details
|
|
Respiratory Tract
> Oropharyngeal conditions
|
|
ORALONE |
| Manufacturer |
|
Taro Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Triamcinolone acetonide 0.1%; dental paste. |
| Indications |
|
Adjunct in oral inflammation. |
| Children |
|
Not recommended. |
| Adults |
|
Press (do not rub) thin film onto lesion at bedtime and, if needed, 2–3 times daily after meals. Reevaluate if no improvement in 7 days. |
| Contraindications |
|
Fungal, viral, or bacterial infections of the mouth or throat. |
| Precautions |
|
Tuberculosis. Peptic ulcer. Diabetes. Pregnancy. |
| Adverse Reactions |
|
Local irritation or sensitization (discontinue if occurs); possible systemic effects (eg, adrenal suppression, glucose intolerance, protein catabolism, peptic ulcer activation). |
| How Supplied |
|
Paste—5g |
|
|
|
|
